The interventions chosen to change diets matter for the shift that can be attained and for the direction and size of the ...

Renal Cell Carcinoma (RCC): FDA approved oral Everolimus for advanced RCC after failure of sunitinib and/or sorafenib. Approval was based on RECORD-1 randomized phase III (everolimus 10 mg PO daily vs ...

The plant will be built in two phases. One will add power to the grid amid rising demand, another will serve data centers via ...

Abstract: Digital commerce platforms face a significant challenge in accurately modeling user preferences from high-dimensional, multimodal data, as traditional methods like collaborative filtering ...

Abstract: The complex interplay of neural and muscular activity underlying involuntary rhythmic wrist tremors poses significant challenges for effective symptom management, particularly with ...

JADE101 is an investigational,potentially best-in-class disease-modifyinganti-APRIL monoclonal antibody, with a Phase 1 healthy volunteer study underway SAN FRANCISCO and VANCOUVER, British Columbia, ...

Tivardi Therapeutics (NASDAQ:TVRD) is down ~85% in Monday trading after reporting that preliminary results from a phase 2 trial of TTI-101 in idiopathic pulmonary fibrosis showed significantly higher ...

WALTHAM, Mass., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven ...

Welcome to Data Breach 101, a Tom's Guide limited series dedicated to smarter online decision making when it comes to your personal data. Scams are more sophisticated than ever, and the best way to ...